Best Adenocarcinoma Doctors Worldwide — TOP 120

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Dr. Vafi Atalay is a colorectal and general surgeon at Anadolu Medical Center. He developed the tube ileostomy technique to eliminate the need for ostomy-closure surgery. This method was published in the journal Colorectal Disease. Dr. Atalay specializes in pancreatic, colon, rectal, and liver cancers.

• Winner of the Gold Medal Award at the Istanbul International Invention Fair.
• Authored over 30 articles in national and international medical journals.
• Received the Best Scientific Research Award from several surgical congresses.
• Practices at a clinic affiliated with the top-ranked Johns Hopkins Hospital.

Over 400 pancreatic and gastric cancer surgeries – Prof. Peker specializes in complex gastrointestinal cancers at Hisar Hospital Intercontinental.

• Trained at Mayo Clinic in hepatopancreatobiliary surgery
• Founder of a Hepatopancreatobiliary Surgery unit in Turkey
• Performs liver, gallbladder, and bile duct surgeries
• Also experienced in obesity-metabolic surgery and kidney transplants

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

As head of Austria's largest oncology department and a leader in immunotherapy, Prof. Zielinski has performed over 1,100 cancer treatments. He now leads the International Oncology Center at Wiener Privatklinik.

• Over 44 years of experience of experience as a prominent oncologist and hematologist
• Founder of the Comprehensive Cancer Center Vienna, integrating care and research
• President of the Central European Cooperative Oncology Group, coordinating international trials
• Author of more than 600 scientific publications on oncology

Dr. Raphael leads Israel's national genomic medicine initiative for oncology and pioneers clinical trials in NSCLC immunotherapy.

• Senior lecturer at Tel Aviv University's Faculty of Medical Sciences
• Principal investigator for multiple NSCLC immunotherapy trials
• Moderator of Israel's Lung Cancer Society Molecular Tumor Board
• Specializes in genomic profiling and liquid biopsy techniques
• Recipient of ESMO and IASLC memberships

Dr. Buhl specializes in neurosurgery with a focus on brain metastasis surgery – a key area in adenocarcinoma treatment. He co-founded a Fund dedicated to brain tumor research.

• Doctor of Medical Sciences with extensive research in neuropathology
• Expert in computerised neuronavigation for precise brain surgeries
• Published 47 scientific papers on neurosurgery topics in 2016 alone
• Performs minimally invasive and endoscopic neurosurgical procedures

Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.

• Authored over 600 peer-reviewed publications in molecular and surgical pathology.
• Specializes in tumor biopsy, immunohistochemistry, and genetic mutation testing.
• Treats complex oncological cases, including glioblastoma and rare sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.

Dr. Pelles Sharon specializes in advanced adenocarcinoma treatments at Sourasky Medical Center, including HIPEC and immunotherapy.

• Expert in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for abdominal cancers
• Provides personalized immunotherapy protocols including Keytruda
• Conducts clinical research on patient attitudes toward cancer trials
• Performs complex Whipple procedures for pancreatic adenocarcinoma

Head of the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – Dr. Merimsky specializes in complex sarcoma cases.

• Over 41 years of experience of experience in orthopedic oncology
• Fellowship-trained at Institut Gustave Roussy in Paris
• Member of ESMO Sarcoma Faculty and IASLC
• Published extensively on bone and soft tissue malignancies

Dr. Sarid specializes in chemotherapy and radiotherapy with over 38 years of experience of oncology experience at Israel's leading Sourasky (Ichilov) Medical Center.

• Educated at Oxford University in cancer urology
• Principal investigator for clinical trials in cancer therapies
• Authored 30+ articles on cancer treatment
• Member of ESMO, ASCO, and Israeli oncology societies

Prof. Andreas Sesterhenn performs 4,000+ surgical interventions annually, specializing in minimally invasive techniques for head and neck tumors.

• 26 years of experience of surgical experience in otolaryngology and oncology
• Performs robotic and endoscopic surgeries with incisions under 1 cm
• Chief Physician at Solingen Clinic's ENT Department since 2012
• Author of 78 scientific publications on head and neck surgery
• Trained at University of the Health Sciences in Bethesda

Dr. Jan Dolezel is a leading onco-urology specialist with 30 years of experience of experience in Da Vinci Robotic Surgery at St. Zdislava Hospital.

• Specialized in laparoscopic and robotic surgeries at University of Strasbourg
• Member of European Society of Urology and Community of Robotic Surgery
• Published 108 scientific papers in medical journals
• Affiliated with Czech Society of Urology and Oncology Federation of Czech

Dr. Arnon Nagler is a hematologist at Sheba Medical Center in Israel. He is a professor at Tel Aviv University and a renowned transplant expert. Dr. Nagler founded Israel’s first public cord blood bank. He also performed the first cord blood transplantations in the country. He completed postdoctoral training at Stanford University and is board-certified in hematology.

• Pioneered reduced–intensity allogeneic transplant protocols for blood cancers.
• Served as Chair of the Acute Leukemia Working Party for the EBMT.
• Published over 400 articles in leading journals like Blood and Leukemia.
• Works at Sheba Medical Center, ranked 7th worldwide by Newsweek in 2026.

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Stephanie Lilianne E. Bolle is a radiation oncologist and Head of Radiation Oncology at the Quirónsalud Proton Therapy Center in Madrid. She has led the department since July 2024. The center is Spain’s first proton therapy facility.

MD, University of Liège (1998). Board certified in radiation oncology (2003). She is an active member of the European Society of Paediatric Oncology and works with its Brain Tumor Group and Radiation Oncology Working Group.

She has published more than 120 scientific articles on pediatric brain tumors, proton therapy, pediatric radiation doses, and complex radiotherapy. She takes part in international projects and clinical trials, including BIOMEDE 2 and HARMONIC. Her expertise includes proton therapy, pediatric oncology, CNS and skull base tumors in adults and children, sarcomas, and complex radiotherapy planning.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Prof. Sezer Sağlam specializes in gastrointestinal oncology with extensive experience at Istanbul University Oncology Institute.

• Professor of Medical Oncology since 2016
• Fellowship-trained at Istanbul University Medical Faculty
• Member of ESMO, ASCO, and ENET
• Works at Gayrettepe Florence Nightingale Hospital

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center in Israel. He was recognized by Forbes as one of the country's top physicians. Prof. Nachmany specializes in robotic surgery for the liver, pancreas, and bile ducts. He focuses on treating gastrointestinal neuroendocrine tumors using minimally invasive techniques.

• Board certified in General Surgery, HPB Surgery, and Abdominal Organ Transplantation.
• Completed surgical fellowships at the prestigious Thomas E. Starzl Transplantation Institute.
• Performs complex Whipple procedures and robotic low anterior resections.
• Author of numerous surgical oncology studies in journals like Cancer Research.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).